ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Boston Meeting To Look At “IRBs At Crsswoad”

August 12, 1988

NCI programs: AIDS Malignancy Program gets new director, authority.

November 4, 2005

SBIR: A Sure Fire Way to Get Funded In A Year When Applications Scoring Over 158 Are Being Dropped

February 22, 1985

NCI News Roundup: clinical Trials Initiatives Explained in Lectures Available Online

June 11, 1999

In Brief: Six Major NIH Positions Now Open; M.D. Anderson Plans More Than $25 Million In Construction

August 21, 1981

Biotheraputices To Reveal Plans for Expansion

August 8, 1986